IS4556A - 17-díflúorómteýlen-östratríen - Google Patents

17-díflúorómteýlen-östratríen

Info

Publication number
IS4556A
IS4556A IS4556A IS4556A IS4556A IS 4556 A IS4556 A IS 4556A IS 4556 A IS4556 A IS 4556A IS 4556 A IS4556 A IS 4556A IS 4556 A IS4556 A IS 4556A
Authority
IS
Iceland
Prior art keywords
hydrogen atom
beta
alpha
östratríen
díflúorómteýlen
Prior art date
Application number
IS4556A
Other languages
English (en)
Inventor
Bohlmann Rolf
Rubanyl Gabor
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of IS4556A publication Critical patent/IS4556A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Ceramic Products (AREA)
  • Vehicle Body Suspensions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrical Control Of Air Or Fuel Supplied To Internal-Combustion Engine (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Exhaust-Gas Circulating Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS4556A 1995-03-13 1997-09-08 17-díflúorómteýlen-östratríen IS4556A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19509729A DE19509729A1 (de) 1995-03-13 1995-03-13 17-Difluormethylen-Estratriene
PCT/EP1996/001069 WO1996028462A1 (de) 1995-03-13 1996-03-13 17-difluormethylen-estratriene

Publications (1)

Publication Number Publication Date
IS4556A true IS4556A (is) 1997-09-08

Family

ID=7756963

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4556A IS4556A (is) 1995-03-13 1997-09-08 17-díflúorómteýlen-östratríen

Country Status (21)

Country Link
US (2) US6018062A (is)
EP (1) EP0815120B1 (is)
JP (1) JPH11501644A (is)
KR (1) KR19980703002A (is)
AT (1) ATE199159T1 (is)
AU (1) AU693335B2 (is)
BR (1) BR9612787A (is)
CA (1) CA2215201A1 (is)
CZ (1) CZ281097A3 (is)
DE (2) DE19509729A1 (is)
HU (1) HUP9801846A3 (is)
IL (1) IL117497A (is)
IS (1) IS4556A (is)
NO (1) NO308306B1 (is)
PL (1) PL322199A1 (is)
RU (1) RU2155770C2 (is)
SI (1) SI9620030A (is)
SK (1) SK121697A3 (is)
TR (1) TR199700950T1 (is)
WO (1) WO1996028462A1 (is)
ZA (1) ZA962037B (is)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU703814B2 (en) * 1995-12-04 1999-04-01 Wyeth Antioxidant
US5773432A (en) * 1996-10-30 1998-06-30 Schering Aktiengesellschaft Method for lowering plasma levels of lipoprotein(a)
EP1654325A1 (en) * 2003-08-11 2006-05-10 Industria Chimica Reggiana I.C.R. S.P.A. Chemical composition and method of polymerisation thereof for use on vehicle bodywork repair
AU2005259499A1 (en) * 2004-06-29 2006-01-12 Jado Technologies Gmbh Use of steroid-derived pharmaceutical compositions for treating disorders relating to pathological processes in lipid rafts
US8030298B2 (en) 2005-05-26 2011-10-04 Abbott Products Gmbh 17β-HSD1 and STS inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3741800A1 (de) * 1987-12-07 1989-06-15 Schering Ag 17-halogenmethylen-estratriene
US5783571A (en) * 1991-01-07 1998-07-21 Pherin Corporation Method of altering hypothalamic function by nasal administration of estrene steroids
US5969168A (en) * 1991-01-07 1999-10-19 Pherin Corporation Androstanes for inducing hypothalamic effects
US5883087A (en) * 1991-01-07 1999-03-16 Pherin Corporation Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US5773432A (en) * 1996-10-30 1998-06-30 Schering Aktiengesellschaft Method for lowering plasma levels of lipoprotein(a)

Also Published As

Publication number Publication date
ATE199159T1 (de) 2001-02-15
SI9620030A (sl) 1998-02-28
IL117497A0 (en) 1996-07-23
DE19509729A1 (de) 1996-09-19
NO974206L (no) 1997-11-13
ZA962037B (en) 1996-09-25
HUP9801846A3 (en) 1999-03-01
MX9707006A (es) 1997-11-29
WO1996028462A1 (de) 1996-09-19
PL322199A1 (en) 1998-01-19
EP0815120B1 (de) 2001-02-14
NO308306B1 (no) 2000-08-28
AU5107896A (en) 1996-10-02
NO974206D0 (no) 1997-09-12
KR19980703002A (ko) 1998-09-05
CA2215201A1 (en) 1996-09-19
SK121697A3 (en) 1998-02-04
EP0815120A1 (de) 1998-01-07
DE59606435D1 (de) 2001-03-22
RU2155770C2 (ru) 2000-09-10
US6136800A (en) 2000-10-24
IL117497A (en) 1999-12-22
TR199700950T1 (xx) 1998-02-21
JPH11501644A (ja) 1999-02-09
AU693335B2 (en) 1998-06-25
HUP9801846A2 (hu) 1998-12-28
CZ281097A3 (cs) 1998-02-18
BR9612787A (pt) 1999-11-23
US6018062A (en) 2000-01-25

Similar Documents

Publication Publication Date Title
NL350077I1 (nl) Cyprosulfamide
TR199801399T2 (xx) Yeni 19-nor-pregnen t�revleri.
HUP0001192A2 (hu) Topiramát és származékainak alkalmazása elhízás kezelésére használható gyógyszerkészítmények előállítására
AR001440A1 (es) Nuevos taxoides, su preparación y composiciones farmacéuticas que los contienen.
TR199801255T2 (xx) Vitronektin resept�r antagonistleri.
DE60012188D1 (de) Fungizide
TR199701146T1 (xx) N�rotensin resept�rleri �zerinde etkili 1-Fenilpirazol-3-Karboksamidler.
DE69716292D1 (de) Benzopyranderivate
TR200201102T2 (tr) Yeni oligosakkaritler, bunların hazırlanması ve bunları içeren ilaç bileşimleri
IT1285770B1 (it) Composti corticoidei
TR199701728T1 (xx) Sialil-Lewis X ve sialil-Lewis A taklitleri olarak digikosilatlanm�� 1,-2-dioller.
ES2178763T3 (es) 1,3 -bis-(n-lactamil)propanos y su empleo farmaceutico y cosmetico.
ATE338576T1 (de) Kosmetische zusammensetzungen
DE59606435D1 (de) 17-difluormethylen-estratriene
DK0852580T3 (da) Fremgangsmåde til fremstilling af dihydroxypyrimidin-derivater
ATE104981T1 (de) Tetracyclische antidepressiva.
TR199700802T2 (xx) Triazin t�revleri.
AR009105A1 (es) Derivados de n-(benzotiazol-2-il) piperidina-1-etanamina, su preparacion y aplicacion en terapeutica
DE59803066D1 (de) Substituierte benzyloxyimino-verbindungen
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
ES2090995T3 (es) Copolimeros de siloxano que contienen grupos viniloxi, su preparacion y utilizacion.
DK0788472T3 (da) Fremgangsmåde til fremstilling af 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalenderivater
DE69614552T2 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
ES2061336T3 (es) 3-(2-cloro-4-(trifluorometil)fenoxi)-1-azetidincarboxamidas que tienen actividad anticonvulsiva.
UY24326A1 (es) Nuevas piperidinas.